All Programs

Use the tool below to view all available Prova Series

Pruritus In PN and AD: Challenge How You Manage Itch
Pruritus In PN and AD: Challenge How You Manage Itch
CME/CE
Pruritus In PN and AD: Challenge How You Manage Itch
1.00 credit
- Peter A. Lio, MD
1.00 credit
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
MinuteCE®
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
0.75 program credits
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Understanding Endocrine Resistance in HR+/HER2- mBC
Understanding Endocrine Resistance in HR+/HER2- mBC
MinuteCE®
Understanding Endocrine Resistance in HR+/HER2- mBC
0.75 program credits
- Kevin Kalinsky MD, MS
0.75 program credits
MinuteCE®
From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
0.75 credits 8 episodes
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 credits 8 episodes
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
MinuteCE®
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
0.75 program credits
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
MinuteCE®
Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC 
0.50 program credits
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
0.50 program credits
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
 Real-World Ready: Practical Tips for Community Oncologists
 Real-World Ready: Practical Tips for Community Oncologists
MinuteCE®
 Real-World Ready: Practical Tips for Community Oncologists
1.00 program credit
- Joshua Richter, MD
- Sagar Lonial, MD, FACP
1.00 program credit
Next-Generation Innovations: The Future of CELMoDs in Myeloma
Next-Generation Innovations: The Future of CELMoDs in Myeloma
MinuteCE®
Next-Generation Innovations: The Future of CELMoDs in Myeloma
1.00 program credit
- Noopur Raje, MD
1.00 program credit
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
MinuteCE®
Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
1.00 program credit
- Joshua Richter, MD
- Sagar Lonial, MD, FACP
1.00 program credit
Molecular Magic: Decoding the Unique Mechanism of CELMoDs
Molecular Magic: Decoding the Unique Mechanism of CELMoDs
MinuteCE®
Molecular Magic: Decoding the Unique Mechanism of CELMoDs
1.00 program credit
- Noopur Raje, MD
1.00 program credit
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
MinuteCE®
Precision Targeting: Matching CELMoDs to the Right Patient With Myeloma
1.00 program credit
- Sagar Lonial, MD, FACP
- Noopur Raje, MD
1.00 program credit
Data Dive: Clinical Evidence Behind CELMoDs
Data Dive: Clinical Evidence Behind CELMoDs
MinuteCE®
Data Dive: Clinical Evidence Behind CELMoDs
1.00 program credit
- Sagar Lonial, MD, FACP
1.00 program credit
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CE
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
0.25 credits
- Maria Fleseriu, MD, FACE
0.25 credits
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
MinuteCE®
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
1.00 program credit
- Hussein Tawbi, MD, PhD
- Sapna Patel, MD
1.00 program credit
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
MinuteCE®
Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
1.00 program credit
- Hussein Tawbi, MD, PhD
- Sapna Patel, MD
1.00 program credit

All Programs

Popular

Title

Share on ReachMD